Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1998 1
1999 1
2002 2
2003 1
2004 2
2006 2
2007 1
2009 2
2010 5
2011 6
2012 8
2013 4
2014 8
2015 9
2016 17
2017 18
2018 22
2019 14
2020 11
2021 14
2022 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 30061276

135 results

Results by year

Filters applied: . Clear all
Page 1
Quality of Life and Radiation-induced Late Toxicity Following Intensity-modulated Versus Three-dimensional Conformal Radiotherapy for Patients with Spinal Bone Metastases: Results of a Randomized Trial.
Sprave T, Verma V, Förster R, Schlampp I, Hees K, Bruckner T, Bostel T, El Shafie R, Nicolay NH, Debus J, Rief H. Sprave T, et al. Anticancer Res. 2018 Aug;38(8):4953-4960. doi: 10.21873/anticanres.12813. Anticancer Res. 2018. PMID: 30061275 Clinical Trial.
Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial.
Sprave T, Verma V, Förster R, Schlampp I, Hees K, Bruckner T, Bostel T, El Shafie RA, Welzel T, Nicolay NH, Debus J, Rief H. Sprave T, et al. BMC Cancer. 2018 Aug 31;18(1):859. doi: 10.1186/s12885-018-4777-8. BMC Cancer. 2018. PMID: 30170568 Free PMC article. Clinical Trial.
Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
Sprave T, Verma V, Förster R, Schlampp I, Bruckner T, Bostel T, Welte SE, Tonndorf-Martini E, Nicolay NH, Debus J, Rief H. Sprave T, et al. Radiother Oncol. 2018 Aug;128(2):274-282. doi: 10.1016/j.radonc.2018.04.030. Epub 2018 May 26. Radiother Oncol. 2018. PMID: 29843899 Free article. Clinical Trial.
Bone density and pain response following intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for vertebral metastases - secondary results of a randomized trial.
Sprave T, Verma V, Förster R, Schlampp I, Hees K, Bruckner T, Bostel T, El Shafie RA, Welzel T, Nicolay NH, Debus J, Rief H. Sprave T, et al. Radiat Oncol. 2018 Oct 30;13(1):212. doi: 10.1186/s13014-018-1161-4. Radiat Oncol. 2018. PMID: 30376859 Free PMC article. Clinical Trial.
Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.
Sahgal A, Myrehaug SD, Siva S, Masucci GL, Maralani PJ, Brundage M, Butler J, Chow E, Fehlings MG, Foote M, Gabos Z, Greenspoon J, Kerba M, Lee Y, Liu M, Liu SK, Thibault I, Wong RK, Hum M, Ding K, Parulekar WR; trial investigators. Sahgal A, et al. Lancet Oncol. 2021 Jul;22(7):1023-1033. doi: 10.1016/S1470-2045(21)00196-0. Epub 2021 Jun 11. Lancet Oncol. 2021. PMID: 34126044 Clinical Trial.
Radiation-induced acute toxicities after image-guided intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with spinal metastases (IRON-1 trial) : First results of a randomized controlled trial.
Sprave T, Verma V, Förster R, Schlampp I, Bruckner T, Bostel T, Welte SE, Tonndorf-Martini E, El Shafie R, Nicolay NH, Debus J, Rief H. Sprave T, et al. Strahlenther Onkol. 2018 Oct;194(10):911-920. doi: 10.1007/s00066-018-1333-z. Epub 2018 Jul 5. Strahlenther Onkol. 2018. PMID: 29978307 Clinical Trial. English.
135 results